227 related articles for article (PubMed ID: 2873741)
1. Coronary heart disease death, nonfatal acute myocardial infarction and other clinical outcomes in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1986 Jul; 58(1):1-13. PubMed ID: 2873741
[TBL] [Abstract][Full Text] [Related]
2. Coronary heart disease and all-causes mortality in the Multiple Risk Factor Intervention Trial: subgroup findings and comparisons with other trials.
Cutler JA; Neaton JD; Hulley SB; Kuller L; Paul O; Stamler J
Prev Med; 1985 May; 14(3):293-311. PubMed ID: 3903734
[TBL] [Abstract][Full Text] [Related]
3. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group.
JAMA; 1982 Sep; 248(12):1465-77. PubMed ID: 7050440
[TBL] [Abstract][Full Text] [Related]
4. Mortality after 10 1/2 years for hypertensive participants in the Multiple Risk Factor Intervention Trial.
Circulation; 1990 Nov; 82(5):1616-28. PubMed ID: 2225366
[TBL] [Abstract][Full Text] [Related]
5. Multiple risk factor intervention trial revisited: a new perspective based on nonfatal and fatal composite endpoints, coronary and cardiovascular, during the trial.
Stamler J; Neaton JD; Cohen JD; Cutler J; Eberly L; Grandits G; Kuller LH; Ockene J; Prineas R;
J Am Heart Assoc; 2012 Oct; 1(5):e003640. PubMed ID: 23316301
[TBL] [Abstract][Full Text] [Related]
6. Mortality after 16 years for participants randomized to the Multiple Risk Factor Intervention Trial.
Circulation; 1996 Sep; 94(5):946-51. PubMed ID: 8790030
[TBL] [Abstract][Full Text] [Related]
7. Relationship between baseline risk factors and coronary heart disease and total mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Prev Med; 1986 May; 15(3):254-73. PubMed ID: 3749007
[TBL] [Abstract][Full Text] [Related]
8. Exercise electrocardiogram and coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):16-24. PubMed ID: 2857061
[TBL] [Abstract][Full Text] [Related]
9. Electrocardiographic abnormalities and coronary heart disease mortality among hypertensive men in the Multiple Risk Factor Intervention Trial.
Rautaharju PM; Neaton JD
Clin Invest Med; 1987 Nov; 10(6):606-15. PubMed ID: 3326700
[TBL] [Abstract][Full Text] [Related]
10. Lung cancer mortality after 16 years in MRFIT participants in intervention and usual-care groups. Multiple Risk Factor Intervention Trial.
Shaten BJ; Kuller LH; Kjelsberg MO; Stamler J; Ockene JK; Cutler JA; Cohen JD
Ann Epidemiol; 1997 Feb; 7(2):125-36. PubMed ID: 9099400
[TBL] [Abstract][Full Text] [Related]
11. Baseline rest electrocardiographic abnormalities, antihypertensive treatment, and mortality in the Multiple Risk Factor Intervention Trial. Multiple Risk Factor Intervention Trial Research Group.
Am J Cardiol; 1985 Jan; 55(1):1-15. PubMed ID: 3880997
[TBL] [Abstract][Full Text] [Related]
12. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
[TBL] [Abstract][Full Text] [Related]
13. Hypertension management in the Multiple Risk Factor Intervention Trial (MRFIT). Six-year intervention results for men in special intervention and usual care groups.
Grimm RH; Cohen JD; Smith WM; Falvo-Gerard L; Neaton JD
Arch Intern Med; 1985 Jul; 145(7):1191-9. PubMed ID: 3893343
[TBL] [Abstract][Full Text] [Related]
14. Baseline characteristics of the diabetic participants in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Barzilay JI; Jones CL; Davis BR; Basile JN; Goff DC; Ciocon JO; Sweeney ME; Randall OS;
Diabetes Care; 2001 Apr; 24(4):654-8. PubMed ID: 11315826
[TBL] [Abstract][Full Text] [Related]
15. Heart rate adjustment of exercise-induced ST-segment depression identifies men who benefit from a risk factor reduction program.
Okin PM; Prineas RJ; Grandits G; Rautaharju PM; Cohen JD; Crow RS; Kligfield P
Circulation; 1997 Nov; 96(9):2899-904. PubMed ID: 9386155
[TBL] [Abstract][Full Text] [Related]
16. The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart disease.
JAMA; 1984 Jan; 251(3):351-64. PubMed ID: 6361299
[TBL] [Abstract][Full Text] [Related]
17. First coronary heart disease event rates in relation to major risk factors: Quebec cardiovascular study.
Dagenais GR; Robitaille NM; Lupien PJ; Christen A; Gingras S; Moorjani S; Meyer F; Rochon J
Can J Cardiol; 1990 Sep; 6(7):274-80. PubMed ID: 2224616
[TBL] [Abstract][Full Text] [Related]
18. Oslo Study Diet and Antismoking Trial. Results after 102 months.
Hjermann I; Holme I; Leren P
Am J Med; 1986 Feb; 80(2A):7-11. PubMed ID: 3511692
[TBL] [Abstract][Full Text] [Related]
19. Lipid Research Clinics Coronary Primary Prevention Trial: results and implications.
Rifkind BM
Am J Cardiol; 1984 Aug; 54(5):30C-34C. PubMed ID: 6382999
[TBL] [Abstract][Full Text] [Related]
20. Sudden death in men with increased risk of myocardial infarction. The MRFIT Programme.
Sherwin R
Drugs; 1984 Oct; 28 Suppl 1():46-53. PubMed ID: 6499702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
